GOLDMAN SACHS GROUP INC: DRUG position timeline

GOLDMAN SACHS GROUP INC held 133,689 DRUG shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

1. period ended2026-06-30

   13F 133,689 shares

   Change vs previous 13F +59,320 shares

   <0.01% of the 13F portfolio, value $9,384,968.

   13F-HR 0000886982-26-000519 filed by GOLDMAN SACHS GROUP INC
   Filed 2026-08-14 (acceptance time not in the bulk data set), ingested 2026-10-06 09:57:27 UTC

   Acceptance time not in the bulk data set (spec §4.2).

2. period ended2026-03-31

   13F 74,369 shares

   Change vs previous 13F +25,822 shares

   <0.01% of the 13F portfolio, value $5,426,706.

   13F-HR 0000886982-26-000274 filed by GOLDMAN SACHS GROUP INC
   Filed 2026-05-15 (acceptance time not in the bulk data set), ingested 2026-10-06 09:58:43 UTC

   Acceptance time not in the bulk data set (spec §4.2).

3. period ended2025-12-31

   13F/A 48,547 shares

   Change vs previous 13F +48,547 shares

   <0.01% of the 13F portfolio, value $3,788,608.

   13F-HR/A 0000886982-26-000093 filed by GOLDMAN SACHS GROUP INC
   Filed 2026-03-25 (acceptance time not in the bulk data set), ingested 2026-10-06 09:58:43 UTC

   Acceptance time not in the bulk data set (spec §4.2).

4. period ended2025-06-30

   13F 0 shares

   Change vs previous 13F -22,222 shares

   13F-HR 0000769993-25-000537 filed by GOLDMAN SACHS GROUP INC
   Filed 2025-08-14 (acceptance time not in the bulk data set), ingested 2026-10-07 18:23:11 UTC

   Acceptance time not in the bulk data set (spec §4.2).

   Exited: the 13F for this period no longer lists the position.

5. period ended2025-03-31

   13F/A 22,222 shares

   Change vs previous 13F not available

   <0.01% of the 13F portfolio, value $801,548.

   13F-HR/A 0000769993-25-000340 filed by GOLDMAN SACHS GROUP INC
   Filed 2025-06-27 (acceptance time not in the bulk data set), ingested 2026-10-07 18:23:11 UTC

   Acceptance time not in the bulk data set (spec §4.2).